Sleep improvement in patients with rheumatoid arthritis treated with upadacitinib in real-world practice: results from the SLEERA study

Abstract Background Sleep impairment is common in rheumatoid arthritis (RA) but has not been extensively studied with wearables and self-observation following treatment. This study investigates the impact of upadacitinib (UPA) on subjective (self-reported) and objective (actigraphy-based) sleep qual...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Thomas Hügle, Heino Prillwitz, Godehard Scholz, Diego Kyburz, Jean Dudler, Kristin Schmiedeberg, Laura Zanisi, Melanie D. Harrer Kuster, Pascal S. Roulin, Andrea Rubbert-Roth
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2026-02-01
Saila:	Arthritis Research & Therapy
Gaiak:	Rheumatoid arthritis Sleep Upadacitinib Wearable Remission
Sarrera elektronikoa:	https://doi.org/10.1186/s13075-026-03766-1
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!